BL Pharmtech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7,151	3,864	10,607	5,024	21,752
Short-Term Investments	0	-	2,600	500	1,000
Cash & Short-Term Investments	7,151	3,864	13,207	5,524	22,752
Cash Growth	85.08%	-70.74%	139.10%	-75.72%	83.78%
Accounts Receivable	762.27	857.1	1,011	9,208	10,364
Other Receivables	42.68	126.49	72.82	1,863	120.06
Receivables	836.15	983.6	1,083	11,071	11,097
Inventory	510.57	1,633	1,893	14,754	7,765
Prepaid Expenses	11.82	116.73	213.11	353.37	60.02
Other Current Assets	73.73	340.05	518.21	909.22	627.19
Total Current Assets	8,584	6,937	16,915	32,612	42,301
Property, Plant & Equipment	3,808	4,129	2,878	42,339	42,899
Long-Term Investments	4,788	13,884	22,056	17,011	26,439
Goodwill	-0	-0	-	8,000	13,151
Other Intangible Assets	75.87	221.15	548.99	1,170	1,538
Long-Term Accounts Receivable	45.31	151.09	0	-	-
Long-Term Deferred Tax Assets	-	-	-	1,532	1,679
Long-Term Deferred Charges	-	-	-	-	3.94
Other Long-Term Assets	791.42	11,031	2,403	1,023	2,330
Total Assets	18,195	36,458	44,802	103,687	130,341
Accounts Payable	314.52	402.83	1,078	2,845	7,254
Accrued Expenses	91.6	53.54	62.56	555.77	447.08
Short-Term Debt	3,172	3,875	-	29,092	7,817
Current Portion of Long-Term Debt	1,300	-	1,410	1,967	12,804
Current Portion of Leases	448.34	390.6	361.19	504.13	422.67
Other Current Liabilities	3,667	1,907	5,054	14,015	8,255
Total Current Liabilities	8,994	6,629	7,965	48,979	37,000
Long-Term Debt	-	1,300	2,343	10,739	20,694
Long-Term Leases	121.34	534.77	148.36	404	156.55
Pension & Post-Retirement Benefits	784.29	609.93	507.07	2,088	2,770
Long-Term Deferred Tax Liabilities	250.17	202.8	252.17	310.39	360
Other Long-Term Liabilities	117.95	2,914	1,787	84.29	3,852
Total Liabilities	10,268	12,190	13,002	62,604	64,832
Common Stock	13,342	4,449	44,485	44,485	44,485
Additional Paid-In Capital	93,713	102,524	101,175	99,995	100,007
Retained Earnings	-100,206	-68,625	-102,983	-95,790	-82,200
Treasury Stock	-9.35	-1.69	-1.69	-1.69	-1.69
Comprehensive Income & Other	1,057	-14,099	-11,257	-14,888	-3,794
Total Common Equity	7,896	24,247	31,419	33,800	58,497
Minority Interest	31.7	21.56	380.35	7,282	7,013
Shareholders' Equity	7,927	24,268	31,799	41,082	65,510
Total Liabilities & Equity	18,195	36,458	44,802	103,687	130,341
Total Debt	5,042	6,100	4,262	42,706	41,894
Net Cash (Debt)	2,110	-2,236	8,945	-37,182	-19,142
Net Cash Per Share	79.09	-83.85	335.15	-1393.08	-726.73
Filing Date Shares Outstanding	26.98	8.89	26.69	26.69	26.69
Total Common Shares Outstanding	26.98	2.67	26.69	26.69	26.69
Working Capital	-410.36	308.53	8,951	-16,367	5,301
Book Value Per Share	292.69	9088.31	1177.16	1266.37	2191.67
Tangible Book Value	7,820	24,025	30,870	24,630	43,807
Tangible Book Value Per Share	289.88	9005.41	1156.59	922.80	1641.29
Land	2,538	2,538	1,812	9,553	9,553
Buildings	2,297	2,297	1,877	21,726	21,726
Machinery	402.84	402.84	396.04	16,835	15,761
Construction In Progress	-	-	-	-	32.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.